Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
4
Neutral
4
Bullish
6
Bearish
27
Neutral
13
Bullish
6
Bearish
23
Neutral
9
Bullish
0
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Shree Ganesh Biotech India Limited specializes in the production, processing, and marketing of high-quality hybrid seeds for various crops including corn, sunflower, cotton, paddy, and grain sorghum.
Originally established as a commercial and investment entity in 1982, the company underwent a significant transformation in 2010 with the merger of Shree Ganesh Bio-Tech (India) Private Limited, shifting its focus to the biotech sector.
The company has a notable history of corporate evolution, adapting to market needs and strategically realigning its business model toward agriculture biotechnology.
Despite initial ventures in property and finance, the company's swift adaptation to the bio-tech domain illustrates a dynamic strategic approach to capture growth in the agri-tech market.
Pharmaceuticals & Biotechnology
Biotechnology
24 Cr
Low Risk
-83.9
34.2
—
0.4
0.97
0.54
Sales CAGR
Profit CAGR
ROE
ROCE
Shree Ganesh Biotech India Ltd (SHREEGANES) is currently trading at 0.61 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shree Ganesh Biotech India Limited specializes in the production, processing, and marketing of high-quality hybrid seeds for various crops including corn, sunflower, cotton, paddy, and grain sorghum. Originally established as a commercial and investment entity in 1982, the company underwent a significant transformation in 2010 with the merger of Shree Ganesh Bio-Tech (India) Private Limited, shifting its focus to the biotech sector. The company has a notable history of corporate evolution, adapting to market needs and strategically realigning its business model toward agriculture biotechnology. Despite initial ventures in property and finance, the company's swift adaptation to the bio-tech domain illustrates a dynamic strategic approach to capture growth in the agri-tech market.
Over the past 52 weeks, Shree Ganesh Biotech India Ltd has traded between a low of ₹0.54 and a high of ₹0.97. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shree Ganesh Biotech India Ltd has a market capitalization of approximately 24.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shree Ganesh Biotech India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -83.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 24.32 Cr, Shree Ganesh Biotech India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shree Ganesh Biotech India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shree Ganesh Biotech India Ltd is -83.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Upcoming Result Date: May 13, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Board Meeting - Financial Results
Shree Ganesh Bio‑Tech (India) Ltd will hold a Board meeting on 14‑May‑2026 to consider and approve audited standalone financial results for the quarter and year ended 31‑Mar‑2026 and any other board business.
Board Meeting - Results
Shree Ganesh Bio-Tech will hold a board meeting on 14 May 2026 to consider and approve the audited standalone financial results for the quarter and year ended 31 March 2026, along with the auditors' reports.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
81.01 | 25 Cr | 27.89 | 2.21 | 0.00 | 8.65 | 10.56 | 6.11 | ||
0.60 | 24 Cr | -83.86 | 0.38 | 0.00 | 0.26 | 0.26 | -0.45 | ||
43.72 | 24 Cr | 11.72 | 12.14 | 0.00 | 73.94 | 98.45 | 1.45 | ||
33.60 | 24 Cr | 38.45 | 0.80 | 0.00 | 2.04 | 5.91 | 0.70 | ||
46.00 | 24 Cr | -102.65 | 0.00 | 0.00 | 18.25 | -230.92 | -328.57 | ||
12.50 | 23 Cr | 27.89 | 0.74 | 0.00 | 2.67 | 6.38 | 0.70 | ||
7.76 | 22 Cr | 10.52 | 0.52 | 0.00 | 3.48 | 6.70 | 1.16 | ||
| Median: 7 Co. | — | 33.60 | 24 Cr | 11.72 | 0.74 | 0.00 | 3.48 | 6.38 | 0.70 |
